← Leaderboards
Karl G. Csaky
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Macular Degeneration”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Rohit Varma · University Of Southern California$50,124,787
- Maureen G Maguire · University Of Pennsylvania$38,506,792
- Martin Friedlander · Scripps Research Institute$35,843,206
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Krzysztof Palczewski · University Of California-Irvine$27,513,979
Research focus
Macular DegenerationRetinal Pigment EpitheliumHuman SubjectClinical TrialsAngiogenesisChoroid UveaFluorescein AngiographyRetina CirculationPathologic ProcessPatient Oriented ResearchHuman Therapy EvaluationMacrophageDisease /Disorder ModelVascular Endothelial Growth FactorsClinical ResearchTransfectionAgingLaboratory RatHistopathologyAdenoviridaeMicroarray TechnologyFibroblastsImmunocytochemistryAngiography
Grant awards (30)
Gene Expression In Cells From Patients With Age-related$0
Z01 · FY2006 · EY · contact PI
Study of an Animal Model Of Choroidal Neovascularization$0
Z01 · FY2006 · EY · contact PI
Study Of Cellular Death In Retinal Pigment Epithelial Ce$0
Z01 · FY2006 · EY · contact PI
Development of Therapies for Age-Related Macular Degener$0
Z01 · FY2006 · EY · contact PI
Study of an Animal Model Of Choroidal Neovascularization$0
Z01 · FY2005 · EY
Therapies for Age-Related Macular Degeneration$0
Z01 · FY2005 · EY
Feeder Vessels In Patients With Neovascular AMD$0
Z01 · FY2005 · EY
Gene Expression In Cells From Patients With AMD$0
Z01 · FY2005 · EY
Study Of Cellular Death In RPE Cells$0
Z01 · FY2005 · EY
Feeder Vessels In Neovascular Macular Degeneration$0
Z01 · FY2004 · EY
Multi-Center, Randomized, Prospective Clinical Trial$0
Z01 · FY2004 · EY
Gene Expression In Cells From Patients With AMD$0
Z01 · FY2004 · EY
Study of an Animal Model Of Choroidal Neovascularization$0
Z01 · FY2004 · EY
Feeder Vessels In Neovascular Macular Degeneration$0
Z01 · FY2003 · EY
Study of an Animal Model Of Choroidal Neovascularization$0
Z01 · FY2003 · EY
Study Of Cellular Death In Retinal Pigment Epithelial Ce$0
Z01 · FY2003 · EY
Gene Expression In Age-related Macular Degeneration$0
Z01 · FY2003 · EY
Prospective Clinical Trial to Celebrex with PDT in AMD$0
Z01 · FY2003 · EY
Development Of An Animal Model Of Choroidal Neovasculari$0
Z01 · FY2002 · EY
Feeder Vessels In Patients With Neovascular Macular Dege$0
Z01 · FY2002 · EY
Gene Expression In Cells From Patients With Age-related$0
Z01 · FY2002 · EY
Study Of Cellular Injury In Retinal Pigment Epithelial C$0
Z01 · FY2002 · EY
Study Of Cellular Injury In Retinal Pigment Epithelial C$0
Z01 · FY2001 · EY
Vessels In Patient With Neovascular Macular Degeneration$0
Z01 · FY2001 · EY
Gene Expression In Macular Degeneration$0
Z01 · FY2001 · EY
Development Of An Animal Model Of Choroidal Neovasculari$0
Z01 · FY2001 · EY
DEVELOPMENT OF ANIMAL MODEL OF CHOROIDAL NEOVASCULARIZAT$0
Z01 · FY2000 · EY
Cellular injury in retinal pigment epithelial cells$0
Z01 · FY2000 · EY
Fluocinolone acetonide in choroidal neovascularization$0
Z01 · FY2000 · EY
OCULAR GENE TRANSFER$0
Z01 · FY2000 · EY